Companies
Verily Debug Project
Wolbachia-infected male mosquito releases — Seeking approval for tens of millions of releases across CA/FL.
- Country
- United States
wolbachia-suppression
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| genome-engineering | ✓ | ✓ | ✓ |
Regulatorsepaemamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Regulatory approval | Seeking Experimental Use Permit from the U.S. EPA for release of Wolbachia-infected male mosquitoes in California and Florida. EPA decision pending. | envirotecmagazine.com · particle.news · thenextweb.com · sfchronicle.com · theguardian.com |
| Capacity | Utilizes automated larval rearing systems, AI-powered mosquito sex-sorting technology, and software-enabled release vehicles. Program has released over 1 billion male mosquitoes globally; Singapore facility releases over 10 million male mosquitoes per week. | envirotecmagazine.com · thenextweb.com |
| Production site | South San Francisco (breeding and sorting); Singapore (international R&D hub and largest adult mosquito production facility). | particle.news · theguardian.com |
| Headcount | Alphabet Inc. reported 194,668 employees as of March 31, 2026. | sqmagazine.co.uk · sec.gov |
| Revenue | Alphabet Inc. reported $109,896 million in revenue for Q1 2026. | sqmagazine.co.uk · sec.gov |
| Funding | Project Debug/Wolbachia mosquito work by the World Mosquito Program has been funded by grants from the Bill & Melinda Gates Foundation, Wellcome Trust, US Agency for International Development, and the UK Government. (Note: Specific funding for Verily/Google Debug project is not detailed in terms of a specific round, though program research is mentioned.) medium confidence | worldmosquitoprogram.org |
Independent sources: envirotecmagazine.com · particle.news · sec.gov · sfchronicle.com · sqmagazine.co.uk · theguardian.com · thenextweb.com · worldmosquitoprogram.org
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Ecological engineering & gene drives | genome-engineering | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.